bpc-157 long-term use safety for athletes and injury treatment: Science, safety, and legal concerns Regeneration or Risk? A Narrative
Description
The primary assumptions were that BPC-157 is highly stable, biocompatible, and sufficient to exert action when presented by itself
therefore, learning one single approach well is recommended as this would suffice for most clinical indications
The newer animal study above puts the half-life at under 30 minutes, and that's the better-supported figure
However, these are rarely needed for standard injection site reactions
